People who are chronically infected with hepatitis B (HBsAg positive) often have no symptoms but can harbor or develop active hepatitis, liver cirrhosis and liver cancer.
Antiviral treatment is indicated if the infected person has active hepatitis or liver cirrhosis and is effective in reducing risk of disease progression and death.
To access the treatment decision tool based on and adapted from the World Health Organization 2015 Hepatitis B Treatment Guidelines. click here
To access the treatment decision tool based on and adapted from the 2018 hepatitis B treatment guidelines from the American Association for the Study of Liver Diseases (AASLD). click here